Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone

NCT03028012 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03028012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03028012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone
Lead sponsor
University of Utah
Phase
Phase 4
Overall status
Terminated
Start date
May 2, 2017
Completion date
May 1, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pain